BrightSpring Health Services Inc
For the period ended Sep 30, 2024. Filed Nov 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Shareholders' Equity
(In thousands, except share data)
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at June 30, 2024 | 171,397,030 | $1,714 | $1,804,965 | $(226,150) | $19,025 | $379 | $1,599,933 |
| Net loss (1) | — | — | — | (8,230) | — | (178) | (8,408) |
| Other comprehensive loss, net of tax | — | — | — | — | (19,730) | — | (19,730) |
| Share-based compensation | — | — | 15,210 | — | — | — | 15,210 |
| Shares issued under share-based compensation plan, including tax effects | 210,696 | 2 | 507 | — | — | — | 509 |
| Shares issued for payment of acquisition | 2,471,251 | 25 | 29,975 | — | — | — | 30,000 |
| Adjustment of redeemable noncontrolling interests to redemption amount | — | — | (2,542) | — | — | — | (2,542) |
| Balances at September 30, 2024 | 174,078,977 | $1,741 | $1,848,115 | $(234,380) | $(705) | $201 | $1,614,972 |
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at June 30, 2023 | 117,883,231 | $1,179 | $779,541 | $(63,110) | $31,549 | $— | $749,159 |
| Net loss (1) | — | — | — | (130,672) | — | — | (130,672) |
| Other comprehensive income, net of tax | — | — | — | — | 13,046 | — | 13,046 |
| Share-based compensation | — | — | 825 | — | — | — | 825 |
| Repurchase of shares of common stock | (81,654) | (1) | (1,299) | — | — | — | (1,300) |
| Shares issued under share-based compensation plan, including tax effects | 55,478 | 1 | 452 | — | — | — | 453 |
| Balances at September 30, 2023 | 117,857,055 | $1,179 | $779,519 | $(193,782) | $44,595 | $— | $631,511 |
(1) Net loss to the Company for the three months ended September 30, 2024 and 2023 excludes $(573) and $548, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
Condensed Consolidated Statements of Shareholders’ Equity (continued)
(In thousands, except share data or otherwise indicated)
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at December 31, 2023 | 117,857,055 | $1,179 | $771,336 | $(200,319) | $12,544 | $670 | $585,410 |
| Net loss (1) | — | — | — | (34,061) | — | (469) | (34,530) |
| Other comprehensive loss, net of tax | — | — | — | — | (13,249) | — | (13,249) |
| Share-based compensation | — | — | 55,194 | — | — | — | 55,194 |
| Shares issued under share-based compensation plan, including tax effects | 318,085 | 3 | 528 | — | — | — | 531 |
| Shares issued for payment of acquisition | 2,570,503 | 26 | 31,055 | — | — | — | 31,081 |
| Adjustment of redeemable noncontrolling interests to redemption amount | — | — | 12,439 | — | — | — | 12,439 |
| Issuance of common stock on initial public offering, net of underwriting discounts and commissions, and offering-related expenses of $36.8 million | 53,333,334 | 533 | 655,952 | — | — | — | 656,485 |
| Proceeds from stock purchase contract issued under tangible equity units, net of underwriting discounts and commissions of $9.1 million | — | — | 321,611 | — | — | — | 321,611 |
| Balances at September 30, 2024 | 174,078,977 | $1,741 | $1,848,115 | $(234,380) | $(705) | $201 | $1,614,972 |
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at December 31, 2022 | 117,860,839 | $1,179 | $778,121 | $(45,716) | $21,192 | $— | $754,776 |
| Net loss (1) | — | — | — | (148,066) | — | — | (148,066) |
| Other comprehensive income, net of tax | — | — | — | — | 23,403 | — | 23,403 |
| Share-based compensation | — | — | 2,100 | — | — | — | 2,100 |
| Repurchase of shares of common stock | (81,654) | (1) | (1,299) | — | — | — | (1,300) |
| Shares issued under share-based compensation plan, including tax effects | 77,870 | 1 | 597 | — | — | — | 598 |
| Balances at September 30, 2023 | 117,857,055 | $1,179 | $779,519 | $(193,782) | $44,595 | $— | $631,511 |
(1) Net loss to the Company for the nine months ended September 30, 2024 and 2023 excludes $(1,395) and $(1,568), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.